Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor gene
- 31 December 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 50 (5) , 355-363
- https://doi.org/10.1016/0024-3205(92)90437-t
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's DiseaseJournal of Neurochemistry, 1988
- Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic DenervationScience, 1985
- Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer typeJournal of the Neurological Sciences, 1984
- Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroupsAnnals of Neurology, 1983
- Measurement of cholinergic drug effects on memory in alzheimer's diseaseNeurobiology of Aging, 1983
- THE NUCLEUS BASALIS IN ALZHEIMER'S DISEASE: CELL COUNTS AND CORTICAL BIOCHEMISTRYNeuropathology and Applied Neurobiology, 1983
- Alzheimer's diseaseJournal of the Neurological Sciences, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Effects of physostigmine and lecithin on memory in Alzheimer diseaseAnnals of Neurology, 1979